Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Torii

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Torii's Japan sales performance.

Gilead poaches Genentech-exec Merdad Parsey for its new CMO

Gilead poaches Genentech-exec Merdad Parsey for its new CMO Company also files potential blockbuster filgotinib in Japan. As new CEO Daniel O’Day continues to overhaul Gilead’s top positions, Roche subsidiary Genentech’s Merdad Parsey has been appointed as ... The Galapagos-partnered drug is due to be

Sarepta rival NS Pharma files Duchenne drug with FDA

Sarepta rival NS Pharma files Duchenne drug with FDA NS Pharma’s Viltolarsen was granted a Rare Paediatric Disease Designation, Orphan Drug Designation and Fast Track Designation in the US and ‘SAKIGAKE designation’ and ‘Orphan drug designation’ in Japan, where

AstraZeneca sells Losec rights as part of refocus strategy

AstraZeneca sells Losec rights as part of refocus strategy This excludes the rights in China, Japan, the US and Mexico, AZ has said. ... The therapy received approval in Japan in June, and is also under regulatory review in China and in the EU.

Democrats’ final pricing plan announced, 250 drugs targeted

Democrats’ final pricing plan announced, 250 drugs targeted Australia, Canada, France, Germany, Japan and the UK.

Democrats reveal pricing plan with 250-drug hit list

Democrats reveal pricing plan with 250-drug hit list Germany, Japan and the UK.

[ Previous 5 results ] 8 9 10 11 12 13 14 15 16 17 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

DEMAND DIVERSITY REPORT 01: Exploring attitudes towards clinical research among people from different ethnic groups in the UK
This report reveals insights from the people themselves, and discusses the starting points for overcoming current challenges....
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative...
OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...

Infographics